It affects nearly half of our elderly 85 years and older.
Currently, clinical trials are ongoing as researchers look for a way to slow the progression of the disease.
A hormone used to treat prostate cancer in men, who also had Alzheimer's disease, is now the focus of a nationwide study.
Researchers found Alzheimer's did not progress among the men who took leuprolide acetate.
Dr. Alan Seigal says,"And so the question is does this hormone specifically given to men with Alzheimer's disease have some unknown clinical input in improving their underlying dementia, slowing the rate of progression."
"Tell me, what's been going on? Are you doing all right? Are you feeling good?"